# Heart Disease in Pregnancy

> Heart disease in pregnancy refers to **any structural, functional, or rhythm-related cardiovascular disorder** present before or developed during pregnancy, potentially affecting maternal and fetal outcomes.

- Leading cause of maternal death in pregnancy

## Types of Heart Disease in Pregnancy

1. **Congenital Heart Diseases (CHD)**

   - Atrial septal defect
   - Ventricular septal defect
   - Patent ductus arteriosus
   - Tetralogy of Fallot
   - Eisenmenger syndrome
   - Transposition of great arteries

2. **Acquired Heart Diseases** (_RICE_)

   - **Rheumatic heart disease (RHD)**

     - Most common in developing countries
     - Common valvular lesions: Mitral stenosis, Aortic stenosis

   - **Ischemic heart disease (IHD)**

     - Rare, increasing due to older maternal age

   - **Cardiomyopathies**

     - Peripartum cardiomyopathy
     - Dilated/hypertrophic cardiomyopathy

   - **Endocarditis, myocarditis**

3. **Arrhythmias**

   - Atrial fibrillation
   - Supraventricular tachycardia

4. **Pulmonary Hypertension**

## Risk Factors

- History of rheumatic fever
- Family history of congenital heart disease
- Connective tissue disorders (e.g. Marfan’s)
- Prior cardiac surgery or intervention
- Maternal diabetes (for fetal CHD)
- Substance abuse (e.g. cocaine, alcohol)
- Prosthetic heart valves
- Aortic stenosis, Mitral stenosis

## Effect of Pregnancy on Heart Disease

- ↑ Blood volume (40–50%) → ↑ preload
- ↑ Cardiac output (30–50%) → ↑ workload
- ↓ Systemic vascular resistance
- Hypercoagulable state → ↑ risk of thromboembolism
- Tachycardia and anaemia may worsen symptoms
  → Can precipitate heart failure, arrhythmias, or embolic events

## Effect of Heart Disease on Pregnancy

### Maternal

- **Heart failure**
- **Arrhythmias**
- **Thromboembolism**
- **Endocarditis**
- **Maternal mortality** (especially NYHA III–IV or pulmonary hypertension)

### Fetal

- **IUGR**
- **IUFD** (40%)
- **Preterm delivery**
- **Prematurity**
- **Stillbirth**
- **Congenital heart disease (if maternal CHD)**

### Physical Examination

- Cyanosis
- Pulse rate and rhythm
- blood pressure
- Features of right heart failure
  - Raised JVP
  - ENlarged and tender liver
  - Dependent edema
  - Bilateral basal creptation
- Precordial examination
  - Apex beat displaced
  - Additional heart sounds

## Investigations

### For Diagnosis

- **Echocardiography** – EF%, valvular lesions, pulmonary pressure
- **ECG** – Rhythm, hypertrophy, ischemia, electrolyte imbalance
- **Chest X-ray (with shielding)** – Cardiomegaly, pulmonary edema

### For Causes

- ASO titre, ESR, CRP (if RHD suspected)
- Blood cultures (if endocarditions suspected)

### For Complications

- CBC (anemia, leucocytosis)
- Urine RE: proteinuria (HF), hematuria (IE)
- BNP (heart failure), coagulation profile
- Oxygen saturation
- Fetal monitoring – growth scan, Doppler studies, NST

## Management

### Pre-Conception

1. **Contraindication**
   - Tight MS (Mitral valve < 1cm)
   - Pulmonary hypertension
   - Eisenmenger syndrome
   - Marfan's aortic root dilatation > 4 cm
1. **Risk Stratification**

   - Use **WHO risk classification**
   - WHO I (low risk) → Normal care
   - WHO IV (very high risk) → Pregnancy contraindicated

1. **Pre-pregnancy counselling**
   - Explain risk of maternal complications and even **death**
   - Inheritance risk of CHD to offspring
   - Risk of preterm labour and IUGR, IUFD, congenital heart disease
   - Other options: Contraception, adoption, surrogacy
   - Timing of pregnancy
   - Medication review: Stop teratogenic drugs
   - Optimize cardiac status: surgical repair if needed
1. **Contraceptive advice** if pregnancy not advised
   - Prefer **progesterone-only methods** or **IUD**
   - Avoid estrogen due to thrombogenic risk

### Antenatal (AN) Care

- **Multidisciplinary care**: Obstetrician + Cardiologist + Anaesthetist

- **Frequent visits** – Monthly to biweekly depending on severity

- **Monitoring**

  - Symptoms: Dyspnoea, fatigue, orthopnea
  - Signs: Murmur changes, edema, arrhythmias
  - Fetal monitoring every 4 weeks if high risk
    - FH, SFH, fetal kick count serially, FHS
    - USG for fetal growth, antenatal CTG, BPP

- **Medications**

  - **Diuretics** (e.g. `Furosemide` 20–40 mg IV/PO) → If signs of fluid overload
  - **Beta-blockers** (e.g. `Metoprolol` 25–100 mg PO/day) → Control HR, arrhythmias
  - `Digoxin` (0.125–0.25 mg/day PO) → For rate control in AF
  - **Anticoagulation**

    - **Mechanical valve**:

      - 1st trimester: LMWH (e.g. `Enoxaparin` 1 mg/kg SC BD) or dose-adjusted `warfarin`
      - 2nd trimester: `Warfarin` preferred if dose \<5 mg/day
      - 3rd trimester: Switch to LMWH or UFH to avoid fetal bleeding

    - Monitor Anti-Xa or INR

- **Avoid** ACE inhibitors, ARBs, statins – teratogenic

### Intrapartum Care

#### 1st Stage (Place, Time, Mode)

- **Place**: Tertiary care with ICU & cardiac facilities
- **Time**: Elective induction at 38–39 weeks if stable
- **Mode**: Vaginal delivery preferred unless obstetric indication for LSCS

#### Labour Management

- **Strict monitoring**

  - O2 sat, ECG, BP, CVP if needed
  - Avoid fluid overload
  - Left lateral position (avoid supine position)

- **Analgesia**: Early epidural anaesthesia → ↓ stress, ↓ preload
- **Antibiotic prophylaxis** for infective endocarditis (controversial, consider if prosthetic valve or past endocarditis)
- Continuous CTG monitoring
- Partogram to assess the progress of labour
- Watch out for complications of heart failure, acute pulmonary oedema

#### 2nd Stage

- Shorten second stage using **assisted vaginal delivery** (vacuum/forceps) to avoid Valsalva

#### 3rd Stage

- Blood loss during delivery → Immediate replacement
- Active management of 3rd stage with `syntocinon` alone
- Avoid `ergometrine` → Can cause hypertension/tachycardia
- Use `oxytocin` infusion (10–20 units in 500 mL over 4–6 hrs)
- Watch for **sudden increase in venous return** after placenta delivery → precipitate failure

### Postpartum Care (Puerperium)

- Broad spectrum antibiotcs
- **Highest risk for cardiac decompensation** in first 24–72 hrs postpartum
- **Monitoring in HDU/ICU**
- Gradual mobilization
- Continue heart failure medications
- **Contraceptive counselling**

  - Avoid combined pills
  - Progestin-only or non-hormonal preferred

### Postnatal Followup

- Adequate rest and continue treatment with cardiologist
- Physical and mental health of mother
- Growth of the baby
- Assess cardiac status
- Advice on birth spacing and family planning

## Treatment of Heart Failure in Pregnancy

> The same as in non-pregnant individual
